A randomized, double-blind, placebo-controlled study of the safety and efficacy of intravenous MCC-135 as an adjunct to primary percutaneous coronary intervention in patients with acute myocardial infarction: Evaluation of MCC-135 for left ventricular salvage in acute myocardial infarction (EVOLVE)

Publication | Closed Access

DOI

Citations

References

2007

Year

Ik–Kyung Jang, Neil J. Weissman, Michael H. Picard, Michael R. Zile, Veronica Pettigrew, Steven S. Shen, Jun Tatsuno, Mark G. Hibberd, Dan Tzivoni, Frans J. Th. Wackers

American Heart Journal

Percutaneous Coronary InterventionThrombosisCardiovascular DiseaseLeft Ventricular SalvagePatient SafetyPlacebo-controlled StudyCardiac CareAcute Myocardial InfarctionMedicineCardiologyEmergency MedicineCoronary Artery DiseaseMyocardial Infarction